=== VARIABELEN ===
Array
(
    [defid] => VWS-WOO-2025.061v1-6085442
    [request_id] => 
)

=== SQL LOG ===
Geen SQL queries.

Array
(
    [id] => ae2ce14f-b6c1-486c-8d74-319318a13a9b
    [Document ID] => 6085442
    [Document naam] => Ter publicatie uiterlijk 299 1e verlenging 3.17a besluit Lithiumcarbonaat Teva 400 mg tabletten.eml
    [Bestandsnaam] => 
    [Beoordeling] => Deels openbaar gemaakt
    [Beoordelingsgrond] => 
    [Toelichting] => 
    [Publieke link] => 
    [Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/4172052-1086189-doo/document/VWS-WOO-2025.061v1-6085442
    [Opgeschort] => 
    [Definitief ID] => VWS-WOO-2025.061v1-6085442
    [Status] => shiningstar
    [FromFile] => https://open.minvws.nl/dossier/VWS-WOO/4172052-1086189-doo
    [DocumentPublicationDate] => 25 september 2022
    [DocumentStatusCheckedDate] => 2026-04-29 01:22:53.107616
    [DocumentStatusCheckedResult] => 200
    [SourceFileType] => 
    [Tags] => 
    [Besluit] => 
    [ModifiedDate] => 2025-12-20 00:12:36.001239+00
    [DeletedDate] => 
    [BesluitURL] => 
    [CreatedDate] => 2025-11-05 18:30:57
    [DocumentDownloadLink] => 
    [DigestLaatsteControleDatum] => 2026-05-31T16:32:01.679666+00:00
    [DocumentDownloadHistory] => [{"url": "https://open.minvws.nl/dossier/VWS-WOO/4172052-1086189-doo/file/download/document/1f0ba5dc-2469-67c8-b19c-1de1cbade2d1", "error": null, "status": "shiningstar", "http_code": 200, "checked_at": "2026-05-31T16:32:01.679666+00:00"}]
)